Hepatocellular carcinoma: current management and perspectives for the future
NN Rahbari, A Mehrabi, NM Mollberg, SA Müller… - Annals of …, 2011 - journals.lww.com
Objective: To review the literature on current management of hepatocellular carcinoma
(HCC). Background: Hepatocellular carcinoma represents one of the most common …
(HCC). Background: Hepatocellular carcinoma represents one of the most common …
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
L Tiong, GJ Maddern - Journal of British Surgery, 2011 - academic.oup.com
Background Despite being one of the commonest causes of cancer-related death around
the world, only 20 per cent of hepatocellular carcinomas (HCCs) are amenable to curative …
the world, only 20 per cent of hepatocellular carcinomas (HCCs) are amenable to curative …
Long-term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among patients with recurrent hepatocellular carcinoma: a randomized clinical trial
Y Xia, J Li, G Liu, K Wang, G Qian, Z Lu, T Yang… - JAMA …, 2020 - jamanetwork.com
Importance Repeat hepatectomy and percutaneous radiofrequency ablation (PRFA) are
most commonly used to treat early-stage recurrent hepatocellular carcinoma (RHCC) after …
most commonly used to treat early-stage recurrent hepatocellular carcinoma (RHCC) after …
[PDF][PDF] Radiofrequency ablation of hepatocellular carcinoma: long‐term results and prognostic factors in 235 Western patients with cirrhosis
G N'Kontchou, A Mahamoudi, M Aout… - …, 2009 - Wiley Online Library
For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is
in some centers considered a first‐line therapeutic option. However, such a strategy is still …
in some centers considered a first‐line therapeutic option. However, such a strategy is still …
Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective …
ZW Peng, YJ Zhang, HH Liang, XJ Lin, RP Guo… - Radiology, 2012 - pubs.rsna.org
Purpose To compare prospectively the effects of radiofrequency (RF) ablation after
transcatheter arterial chemoembolization (TACE) with those of RF ablation alone in the …
transcatheter arterial chemoembolization (TACE) with those of RF ablation alone in the …
[HTML][HTML] 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma
Korean Liver Cancer Study Group - 2015 - gutnliver.org
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular
Carcinoma Login to Submission Gut and Liver 2021 Impact Factor 4.321 Indexed In …
Carcinoma Login to Submission Gut and Liver 2021 Impact Factor 4.321 Indexed In …
Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma
Background Intrahepatic recurrence of hepatocellular carcinoma (HCC) following resection
is common. However, no current consensus guidelines exist to inform management …
is common. However, no current consensus guidelines exist to inform management …
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm
K Mohkam, PN Dumont, AF Manichon, JC Jouvet… - Journal of …, 2018 - Elsevier
Background & Aims No-touch multibipolar radiofrequency ablation (NTM-RFA) represents a
novel therapy that surpasses standard RFA for hepatocellular carcinoma (HCC), but it has …
novel therapy that surpasses standard RFA for hepatocellular carcinoma (HCC), but it has …
[HTML][HTML] Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus
T Wen, C Jin, A Facciorusso, M Donadon… - … surgery and nutrition, 2018 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the sixth-most common cancer and the third leading
cause of cancer-related death in the world. However, 40–70% patients eventually suffer from …
cause of cancer-related death in the world. However, 40–70% patients eventually suffer from …
The latest research progress on minimally invasive treatments for hepatocellular carcinoma
YW Zou, ZG Ren, Y Sun, ZG Liu, XB Hu… - … & Pancreatic Diseases …, 2023 - Elsevier
Background Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related
death worldwide. Due to the high prevalence of hepatitis B virus (HBV) infection in China …
death worldwide. Due to the high prevalence of hepatitis B virus (HBV) infection in China …